Normalized Income after Taxes: A company's after tax profit or loss smoothed out by elimination of all non-recurring items.
Decoy Therapeutics Inc (DCOY) had Normalized Income after Taxes of $-8.98M for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-8.98M |
|
-- |
|
-- |
|
$9.03M |
|
$-9.03M |
|
$0.06M |
|
$-8.98M |
|
$-8.98M |
|
$-8.98M |
|
$-8.98M |
|
$-8.98M |
|
|
Normalized Income after Taxes |
$-8.98M |
$-9.03M |
|
$-9.03M |
|
0.10M |
|
0.10M |
|
$159.00 |
|
$159.00 |
|
| Balance Sheet Financials | |
$10.99M |
|
$0.04M |
|
$0.07M |
|
$11.06M |
|
$5.17M |
|
-- |
|
-- |
|
$5.17M |
|
$5.89M |
|
$5.89M |
|
$5.89M |
|
0.53M |
|
| Cash Flow Statement Financials | |
$-4.83M |
|
$0.76M |
|
$12.34M |
|
$2.43M |
|
$10.71M |
|
$8.28M |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.13 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-5.40M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-152.45% |
|
-152.45% |
|
-81.20% |
|
-152.45% |
|
$11.07 |
|
$-55.73 |
|
$-49.78 |
|